QSP model building in patients with atopic dermatitis after treatment with nemolizumab

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1050240261

Enrollment

338

Registered

2025-02-05

Start date

2025-02-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Various information (subject background, laboratory values, clinical scores, etc.) obtained in clinical studies in AD patients and healthy subjects (jRCT2080223684, jRCT2080223838, jRCT2080225290, jRCT1030230474) and, where appropriate, in vitro and in vivo data will be used.

Exclusion criteria

Exclusion criteria: Various information (subject background, laboratory values, clinical scores, etc.) obtained in clinical studies in AD patients and healthy subjects (jRCT2080223684, jRCT2080223838, jRCT2080225290, jRCT1030230474) and, where appropriate, in vitro and in vivo data will be used.

Design outcomes

Primary

Measure	Time frame
This study will perform modeling a mathematical model using laboratory values and clinical scores of healthy people and AD patients. The goodness of fit of the model is assessed using an evaluation value calculated from the difference between predicted and measured values when adjusting the model parameters.	—

Contacts

Public ContactSusumu Hashimoto

Maruho Co.,Ltd. Kyoto R&D Center

hashimoto_dcl@mii.maruho.co.jp+81-75-325-3255

Outcome results